Abstract
Ocular surface diseases (OSD) in their most severe forms, such as dry eye, chemical burns, limbal cell deficiency and neurotrophic disease, still have major treatment challenges. In the quest for precision and regenerative medicine, several cell types and sources have been discovered, tracked, and used in experimental, preclinical and clinical studies, such as adult stem cells (SC). This …